Roivant Sciences Director Meghan Fitzgerald Files Form 144 to Sell $698.6K in Common Stock

Insider Filing Analysis: Form 144 Notice of Proposed Sale

Transaction Overview

Roivant Sciences Ltd. Director Meghan Fitzgerald has submitted a Form 144 notice of proposed sale for 20,000 shares of common stock, representing an estimated aggregate market value of $698,600.00 ($34.93 per share).

Key Details

• Filer: Meghan Fitzgerald, Director
• Securities to be Sold: 20,000 Common Shares
• Nature of Acquisition: Exercise of stock options on September 8, 2026, paid in cash.
• Trading Plan: Executed pursuant to a pre-scheduled Rule 10b5-1 trading plan adopted on March 30, 2026.
• Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
• Prior Transactions: 10,000 shares sold on June 30, 2026, for gross proceeds of $349,000 under the same 10b5-1 plan.

Market & Trading Significance

• Trading Significance: Low
• Context: The proposed sale accounts for a very minor fraction (~0.0028%) of Roivant's 722,323,015 outstanding shares. Because the transaction originates from an option exercise under a pre-established Rule 10b5-1 plan, it represents routine liquidity/compensation management rather than discretionary market timing.